202 related articles for article (PubMed ID: 15514573)
1. Saphenous vein graft disease.
Peykar S; Angiolillo DJ; Bass TA; Costa MA
Minerva Cardioangiol; 2004 Oct; 52(5):379-90. PubMed ID: 15514573
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
[TBL] [Abstract][Full Text] [Related]
3. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
Brodie BR; VerSteeg DS; Brodie MM; Hansen C; Richter SJ; Stuckey TD; Gupta N; Pulsipher M; Downey W
Catheter Cardiovasc Interv; 2005 Aug; 65(4):504-9. PubMed ID: 15988742
[TBL] [Abstract][Full Text] [Related]
4. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
[TBL] [Abstract][Full Text] [Related]
5. Distal embolic protection for SVG interventions: can we afford not to use it?
Shaia N; Heuser RR
J Interv Cardiol; 2005 Dec; 18(6):481-4. PubMed ID: 16336429
[TBL] [Abstract][Full Text] [Related]
6. Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.
Ellis SG; Kandzari D; Kereiakes DJ; Pichard A; Huber K; Resnic F; Yakubov S; Callahan K; Borgman M; Cohen SA
J Invasive Cardiol; 2007 Oct; 19(10):404-9. PubMed ID: 17906340
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes.
Abdel-Karim AR; Banerjee S; Brilakis ES
J Invasive Cardiol; 2010 Jun; 22(6):253-7. PubMed ID: 20516502
[TBL] [Abstract][Full Text] [Related]
8. [Strategy for post coronary artery bypass grafting in patients with bypass graft stenosis: comparison of percutaneous transluminal coronary angioplasty for the native coronary artery, internal mammary artery and saphenous vein graft].
Kawaguchi R; Hoshizaki H; Oshima S; Ito S; Hiratsuji T; Tsurugaya H; Ito I; Sekiguchi M; Takama N; Seta Y; Adachi H; Toyama T; Naito S; Kaneko T; Taniguchi K
J Cardiol; 2001 Nov; 38(5):239-44. PubMed ID: 11729723
[TBL] [Abstract][Full Text] [Related]
9. Embolic protection devices in saphenous vein graft interventions.
Cragun DT; Heuser RR
J Interv Cardiol; 2006 Dec; 19(6):525-9. PubMed ID: 17107367
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
11. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
[TBL] [Abstract][Full Text] [Related]
12. The use of drug-eluting stents in venous coronary artery bypass grafts.
Hernandez-Antolín R; Alfonso F; Jimenez P
EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.
Minutello RM; Bhagan S; Sharma A; Slotwiner AJ; Feldman DN; Cuomo LJ; Wong SC
J Interv Cardiol; 2007 Dec; 20(6):458-65. PubMed ID: 18042050
[TBL] [Abstract][Full Text] [Related]
14. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
[TBL] [Abstract][Full Text] [Related]
15. DES for SVG stenosis -- we all want to do it, but are we there yet?
Smith CS; Yeghiazarians Y
J Invasive Cardiol; 2007 Oct; 19(10):410-1. PubMed ID: 17906341
[No Abstract] [Full Text] [Related]
16. Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
Mehta RH; Honeycutt E; Peterson ED; Granger CB; Halabi AR; Shaw LK; Smith PK; Califf RM; Harrington RA; Sketch MH
Circulation; 2006 Jul; 114(1 Suppl):I396-401. PubMed ID: 16820607
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention.
Chu WW; Rha SW; Kuchulakanti PK; Cheneau E; Torguson R; Pinnow E; Alexieva-Fournadjiev J; Pichard AD; Satler LF; Kent KM; Lindsay J; Waksman R
Am J Cardiol; 2006 Jan; 97(1):34-7. PubMed ID: 16377280
[TBL] [Abstract][Full Text] [Related]
18. Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents?
Vermeersch P; Agostoni P
J Interv Cardiol; 2005 Dec; 18(6):467-73. PubMed ID: 16336427
[TBL] [Abstract][Full Text] [Related]
19. Clinical follow-up of paclitaxel-eluting (TAXUS) stents for the treatment of saphenous vein graft disease.
Ruchin PE; Faddy SC; Muller DW; Baron DW; Roy PR; Wilson SH
J Interv Cardiol; 2007 Aug; 20(4):258-64. PubMed ID: 17680855
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous saphenous vein graft intervention--a review.
Hiscock M; Oqueli E; Dick R
Heart Lung Circ; 2007; 16 Suppl 3():S51-5. PubMed ID: 17606404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
